Intuitive Surgical says US business decelerating; growth drivers stable

0 min read | Published on 09 Sept 2026, 06:39 PM |Updated on 09 Sept 2026, 06:39 PM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

Intuitive Surgical's U.S. business is currently decelerating
The U.S. segment accounts for approximately 60% of total operations
Management expects growth drivers to remain consistent in 2026 YoY

*this image is generated using AI for illustrative purposes only.

Intuitive Surgical executive comments indicate the company's U.S. business is decelerating. This segment accounts for approximately 60% of the company's total operations.

The remarks were made during a recent conference call with investors and analysts.

Outlook for 2026

Despite the current deceleration in the U.S. market, management expects the company's growth drivers to remain broadly consistent on a year-over-year basis in 2026.

What the Numbers Show

The U.S. market represents a significant concentration of risk for Intuitive Surgical, contributing roughly 60% of its operational footprint. Any sustained deceleration in this region will have an outsized impact on overall corporate performance compared to other geographies.

What specific strategies is Intuitive Surgical implementing to offset the U.S. deceleration through accelerated international expansion in 2026?

How might the current U.S. slowdown impact the company's capital allocation decisions, such as R&D spending for next-generation robotic platforms?

Are there emerging regulatory or reimbursement hurdles in the U.S. market that could prolong this deceleration beyond the expected 2026 outlook?

Intuitive Surgical $1000 investment from 20 years ago worth $36,576 today

1 min read | Published on 22 Aug 2026, 02:37 AM |Updated on 22 Aug 2026, 02:37 AM

Reviewed by

Ritika DScanX News Team

Add as a preferred
source on Google

Key Highlights

A $1,000 investment in Intuitive Surgical 20 years ago is now worth $36,576.44
The stock delivered a 19.77% annualized return over the past two decades
Intuitive Surgical outperformed the broader market by 10.53% annually
The company currently has a market capitalization of $135.97 billion
Current share price is $379.50

*this image is generated using AI for illustrative purposes only.

Intuitive Surgical (NASDAQ: ISRG) has delivered substantial long-term value to investors, with a $1,000 investment made two decades ago growing to $36,576.44 today. The surgical robotics company currently holds a market capitalization of $135.97 billion.

The stock’s performance highlights the power of compounded returns over extended periods. Intuitive Surgical generated an average annual return of 19.77% over the last 20 years. This figure represents an outperformance of 10.53% against the broader market on an annualized basis.

What the Numbers Show

The divergence between Intuitive Surgical’s total annualized return and its market outperformance reveals the baseline market performance during this period. By subtracting the 10.53% outperformance from the 19.77% total return, the implied average annual market return over this 20-year window was approximately 9.24%. This calculation underscores that while the broader market provided solid double-digit adjacent growth, Intuitive Surgical more than doubled that benchmark through superior operational execution and sector dominance.

Metric	Value
Initial Investment	$1,000
Current Value	$36,576.44
Annualized Return	19.77%
Market Outperformance	10.53%
Market Cap	$135.97 billion

The current share price stands at $379.50. This valuation reflects sustained investor confidence in the company’s da Vinci surgical system and its recurring revenue model from instruments and service contracts. The data illustrates how consistent high-single-digit to low-double-digit growth rates, when compounded over twenty years, can transform modest capital into significant wealth.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Can Intuitive Surgical maintain its historical 19.77% annualized growth rate as the surgical robotics market matures and faces increased competition from Medtronic and Johnson & Johnson?

How might emerging AI-driven surgical technologies or minimally invasive competitors disrupt Intuitive Surgical's current dominance in the da Vinci system ecosystem?

What impact will potential regulatory changes in healthcare reimbursement models have on the company's recurring revenue streams from instruments and service contracts?